Avanir Pharmaceuticals Inc $5.55

down 0.00


9/7/2014 04:00 PM  |  NASDAQ : AVNR  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get AVNR Trend Analysis - it has outperformed the S&P 500 by 7%

Partner Headlines

  1. AVANIR Pharma Offers Three Presentations for AVP-825 for Acute Treatment ...

    Benzinga
  2. Morning Market Movers

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Avanir Pharmaceuticals Announces Data Presentation of Central Nervous System ...

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application ...

    Benzinga
  8. Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board ...

    Benzinga
  9. Avanir Pharmaceuticals Announces Submission of New Drug Application for ...

    Benzinga
  10. Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues ...

    Benzinga
  11. Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares ...

    Benzinga
  12. Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates

    Benzinga
  13. Morning Market Losers

    Benzinga
  14. Benzinga's Top #PreMarket Losers

    Benzinga
  15. Benzinga's Top Downgrades

    Benzinga
  16. Earnings Scheduled For December 10, 2013

    Benzinga
  17. Earnings Expectations For The Week Of December 9

    Benzinga
  18. Avanir Pharma Reports Enrollment of First Patient in Study of AVP-923

    Benzinga
  19. Mid-Afternoon Market Update: Apple Plummets Downwards As Markets Remain ...

    Benzinga
  20. Mid-Day Market Update: Dow Jumps More Than 1%; Apple Shares Drop

    Benzinga
  21. Mid-Morning Market Update: Markets Surge; Packaging Corp To Acquire Boise ...

    Benzinga
  22. Benzinga's Top Pre-Market Gainers

    Benzinga
  23. Market Wrap For Friday, September 13: Markets Erase August Losses On Light ...

    Benzinga
  24. Mid-Afternoon Market Update: Markets Green as Avanir Plummets

    Benzinga
  25. Benzinga's Top Pre-Market Losers

    Benzinga
  26. Avanir Shares Rebound As Analysts Offer Defense On Heels of 13% Drop

    Benzinga
  27. Wedbush Reiterates Outperform on Avanir Pharmaceuticals on Buying Opportunity ...

    Benzinga
  28. Investors In Avanir Cheer As Piper Jaffray Lifts Target On Stock Sharply ...

    Benzinga
  29. Benzinga's Top Pre-Market Gainers

    Benzinga
  30. Avanir Pharma Reports Publication of PRISM Registry Findings

    Benzinga
  31. Mid-Day Market Update: Brocade Surges On Upbeat Results, Cree Shares Fall

    Benzinga
  32. Stocks Hitting 52-Week Highs

    Benzinga
  33. Mid-Morning Market Update: Markets Open Lower, Deere Posts Higher Q3 Profit

    Benzinga
  34. Avanir Pharma Reports Settlement of NUEDEXTA Patent Litigation with Sandoz

    Benzinga
  35. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation ...

    Benzinga
  36. Mid-Afternoon Market Update: Apple Rises Sharply On Icahn Stake, NASDAQ ...

    Benzinga
  37. Mid-Day Market Update: US Stocks Edge Higher; Valspar Shares Decline On ...

    Benzinga
  38. Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down ...

    Benzinga
  39. Benzinga's Top Pre-Market Gainers

    Benzinga
  40. Avanir Pharmaceuticals Reports Operating Results (10-Q)

    GuruFocus
  41. Benzinga's Top Pre-Market Losers

    Benzinga
  42. UPDATE: Piper Jaffray Initiates Coverage on Avanir Pharmaceuticals with ...

    Benzinga
  43. Avanir Pharmaceuticals Reports Operating Results (10-K)

    GuruFocus
  44. Earnings Scheduled For December 12, 2012

    Benzinga
  45. AVANIR Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 18,25 ...

    GuruFocus
  46. Health Care Sector Wrap

    FoxBusiness
  47. Avanir Pharmaceuticals Reports Operating Results (10-Q)

    GuruFocus
  48. Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent ...

    Benzinga
  49. Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals ...

    GuruFocus
  50. Ultimate Stock Watch List for The Supreme Court's Health Care Ruling

    Benzinga
Trading Center